| Identification | Back Directory | [Name]
(R)-2-((5-(1H-indazol-5-yl)pyridin-3-yl)amino)-2-phenylethan-1-ol Benzeneethanol, beta-[[5-(1H-indazol-5-yl)-3-pyridinyl]amino]-, (betaR)- | [CAS]
1613638-82-6 | [Synonyms]
CDK8-IN-4
(R)-2-((5-(1H-indazol-5-yl)pyridin-3-yl)amino)-2-phenylethan-1-ol Benzeneethanol, beta-[[5-(1H-indazol-5-yl)-3-pyridinyl]amino]-, (betaR)- | [Molecular Formula]
C20H18N4O | [MDL Number]
MFCD31657394 | [MOL File]
1613638-82-6.mol | [Molecular Weight]
330.39 |
| Chemical Properties | Back Directory | [Boiling point ]
631.2±55.0 °C(Predicted) | [density ]
1.329±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Solid | [pka]
13.20±0.40(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Description]
VFN38826, also known as CDK8-IN-4, is a CDK8 inhibitor. VFN38826 was first reported in patent WO2014090692A1, compound example 16, with an IC50 of 0.2 nM. This product has no formal name at the moment. |
|
|